文献速递外周动脉疾病

多数因慢性肢体威胁性缺血行大截肢患者术前未接受血运重建且死亡率增高

The majority of patients undergoing major leg amputations for chronic limb-threatening ischemia do not undergo revascularization prior to amputation and have increased mortality.
PubMed 文献 · J Vasc Surg · 2025-07-28

本研究基于TriNetX数据库2000至2020年数据,纳入5328例首次行膝下或膝上大截肢的外周动脉疾病患者,比较截肢前无血运重建(3110例)与有血运重建(2328例)两组的术后结局。结果显示无血运重建组1年死亡率32%对28.1%、3年死亡率45.6%对40.4%均更高,多因素校正后血运重建史与1年及3年死亡率降低独立相关。

要点

  • 因慢性肢体威胁性缺血行大截肢的患者中,多数术前未接受血运重建。
  • 截肢前有血运重建史者1年及3年死亡率均更低。
  • 血运重建次数越多,术后死亡风险越低。

核心结论

  • 截肢前接受血运重建尝试的患者,大截肢术后1年和3年死亡率更低。
  • 这些患者更常接受最佳药物治疗,且截肢前血运重建次数与最终截肢前保肢时间相关。

研究设计与样本

  • 基于TriNetX数据库的回顾性队列研究,查询2000至2020年首次行膝下或膝上大截肢的外周动脉疾病患者。
  • 共5328例纳入分析,分为截肢前无干预史组(3110例)和有单次或多次血管干预史组(2328例)。
  • 主要结局为术后1年和3年死亡率,次要结局包括30天和1年的心肌梗死、肺栓塞、卒中、深静脉血栓、心力衰竭、心律失常和主要不良心脏事件。

关键数值与推荐

  • 亚组分析显示,随着干预次数增加,死亡风险降低:AOR 0.81(95%CI 0.72-0.92);AOR 0.67(95%CI 0.53-0.86);AOR 0.66(95%CI 0.42-1.05)。

临床怎么用

  • 对慢性肢体威胁性缺血患者,应评估血运重建的可行性,避免直接行大截肢。
  • 截肢前尝试血运重建可能改善术后生存,并应同时优化药物治疗。

局限性

  • 本研究为回顾性数据库分析,可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many patients with chronic limb-threatening ischemia (CLTI) undergo lower extremity amputations, and recent data have shown that revascularization operations are not offered to many patients with CLTI, who may benefit from such operations. This study aimed to evaluate the proportion of patients with CLTI who undergo major lower extremity amputation without prior revascularization attempts and to assess postoperative outcomes among all patients undergoing major lower extremity amputations, using data from a large national database. METHODS: The TriNetX database was queried for all peripheral arterial disease patients from 2000 to 2020 who underwent first-time major lower extremity amputation (at either the below the knee level or above the knee level). This sample was divided into two cohorts: No history of interventions before amputation (group I) vs history of single or multiple vascular interventions before amputation (group II). The primary outcome was mortality at 1 and 3 years postoperatively. Secondary outcomes included myocardial infarction, pulmonary embolism, stroke, deep vein thrombosis, heart failure, dysrhythmias, and major adverse cardiac events assessed at 30 days and 1 year. Group II was further divided into subgroups based on the number of revascularization attempts: 0, one to four, five to eight, and more than eight. Univariate analysis was performed via the t test and the χ2 test. Multivariable logistic regression was performed to assess the association of revascularization history with mortality. Significance was set at a P value of less than .05. RESULTS: A total of 5328 patients met inclusion criteria. Group I included 3110 patients and group II included 2328 patients. Group I patients were more likely to be younger, non-White, and have a history of hypertension, hyperlipidemia, heart failure, chronic obstructive pulmonary disease, and coronary artery disease. Group I demonstrated increased mortality at both 1 years (32% vs 28.1%; adjusted P = .005) and 3 years (45.6% vs 40.4%; adjusted P < .001) postoperatively. Furthermore, these patients experienced more major adverse cardiac events (12.4% vs 10.4%; P = .021) at the 30-day timepoint. Multivariable-adjusted analysis confirmed that history of revascularization was associated with a decreased risk of 1-year mortality (adjusted odds ratio [AOR], 0.82; 95% confidence interval [CI], 0.73-0.94; P = .003) and 3 -year mortality (AOR, 0.78' 95% CI, 0.70-0.88; P<.001). Subgroup analysis demonstrated lower mortality risk with greater number of interventions (AOR, 0.81 [95% CI, 0.72-0.92]; AOR, 0.67 [95% CI, 0.53-0.86]; and AOR, 0.66 [95% CI, 0.42-1.05]). CONCLUSIONS: Patients who undergo revascularization attempts before major lower extremity amputation are less likely to experience mortality at 1 and 3 years postoperatively. These patients also received the best medical therapy more often, and the number of revascularizations before amputation correlated with the duration of limb preservation before ultimate amputation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ali T, Samaan F, Soucy JW, et al. The majority of patients undergoing major leg amputations for chronic limb-threatening ischemia do not undergo revascularization prior to amputation and have increased mortality. J Vasc Surg. 2025. PMID: 40738230. doi:10.1016/j.jvs.2025.07.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。